GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Stopped early · Phase 3
Conditions studied: Prostate Cancer
In brief
The purpose of this study is to compare the duration of survival between GVAX® immunotherapy for prostate cancer and chemotherapy treatment in patients with prostate cancer who no longer respond to hormone therapy, who have documented metastases, and who have not been treated with chemotherapy in the past.
Key facts
- Study ID
- NCT00089856
- Run by
- Cell Genesys
- People needed
- 626
- Starts
- 2004-07-01
- Expected to finish
- 2008-10-01
- Last updated by the study team
- 2008-11-05
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Confirmed diagnosis of or clinical history consistent with adenocarcinoma of the prostate
- Metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy
- Detectable metastases
- Any Gleason score
- ECOG performance status 0-2
You may not qualify if…
- Prior treatment with chemotherapy
- Prior Immunotherapy
- Prior treatment with gene therapy
- Significant cancer related pain
Where it is running
- Alaska Clinical Research Center — Anchorage, Alaska, United States
- Palo Verde Hematology/Oncology — Glendale, Arizona, United States
- Mayo Clinic Scottsdale — Scottsdale, Arizona, United States
- ACRC/Arizona Clinical Res. Ctr. Inc. — Tuscon, Arizona, United States
- Arkansas Cancer Research Center — Little Rock, Arkansas, United States
- Compassionate Cancer Care Medical Group, Inc. — Corona, California, United States
- Pacific Coast Hem Onc. Medical Group — Fountain Valley, California, United States
- California Cancer Care — Greenbrae, California, United States
- Center for Urological Research — La Mesa, California, United States
- Oncology Care Medical Associates — Montebello, California, United States
- UC Irvine Medical Center — Orange, California, United States
- San Bernardino Urological Associates — San Bernardino, California, United States
- Sharp Healthcare — San Diego, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- Cancer Research & Prevention Center — Soquel, California, United States
- San Diego Cancer Center — Vista, California, United States
- Univ. of Colorado Health Science Center — Aurora, Colorado, United States
- Cancer Center of Colorado Springs — Colorado Springs, Colorado, United States
- The Hope Clinic — Bristol, Connecticut, United States
- Urology Center of Grove Hill — New Britain, Connecticut, United States
- Carl & Dorothy Bennett Cancer Center — Stamford, Connecticut, United States
- Boca Raton Community Hospital, Inc. — Boca Raton, Florida, United States
- Michael and Dianne Bienes Comprehensive Cancer Center, Holy Cross Hospital — Fort Lauderdale, Florida, United States
- Integrated Community Oncology Network — Jacksonville, Florida, United States
- Central Alabama Oncology, LLC — Alabaster, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.